BackEmergent BioSolutions Overview

Emergent BioSolutions Inventory

Latest inventory for 0IGA.L: $300M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$303.60M
↓ 10.34% YoYΔ $-35.00M vs prior year quarter

Peer trimmed avg / median

Loading

Emergent BioSolutions Inventory History

Loading

Emergent BioSolutions vs. peers: Inventory Comparison

Loading

Emergent BioSolutions Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Emergent BioSolutions (0IGA.L) FAQ

As of the most recent data (June 2026), 0IGA.L shows a inventory of $300M. That compares with $340M in the prior-year period — down 10.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 0IGA.L's inventory is now $300M (was $340M) — a 10.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Emergent BioSolutions is outperforming or lagging.

Tracking 0IGA.L's inventory over time shows whether Emergent BioSolutions is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $340M in the prior-year period — down 10.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Emergent BioSolutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $300M) with ownership activity and broader fundamentals.

Emergent BioSolutions's inventory is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.